Home > Compound List > Product Information
3-Quinolineboronic acid_Molecular_structure_CAS_191162-39-7)
Click picture or here to close

3-Quinolineboronic acid

Catalog No. 709522 Name Sigma Aldrich
CAS Number 191162-39-7 Website http://www.sigmaaldrich.com
M. F. C9H8BNO2 Telephone 1-800-521-8956
M. W. 172.97632 Fax
Purity Email
Storage Chembase ID: 10048

SYNONYMS

Title
3-喹啉硼酸
IUPAC name
(quinolin-3-yl)boronic acid
IUPAC Traditional name
quinolin-3-ylboronic acid
Synonyms
(3-Quinolyl)boronic acid
(3-Quinolinyl)boronic acid
Quinolin-3-ylboronic acid

DATABASE IDS

MDL Number MFCD02183527
CAS Number 191162-39-7

PROPERTIES

Empirical Formula (Hill Notation) C9H8BNO2
Melting Point 191-196 °C
GHS Pictograms GHS07
GHS Signal Word Warning
GHS Hazard statements H315-H319-H335
European Hazard Symbols Irritant Irritant (Xi)
MSDS Link Download
GHS Precautionary statements P261-P305 + P351 + P338
Risk Statements 36/37/38
Safety Statements 26-36-37
Storage Temperature 2-8°C
German water hazard class 3

DETAILS

Description (English)
General description
May contain varying amounts of anhydride
Packaging
1 g in glass bottle
Application
Reactant for:
• Preparation of P1-substituted symmetry-based human immunodeficiency virus protease inhibitors with antiviral activity against drug-resistant viruses1
• Preparation of heterobiaryls via Suzuki-Miyaura cross-coupling with heteroaryl halides in continuous flow2
• Preparation of Ph and heterocyclic(pyridinyl)pyrazolyl)pyridines as TGF-1 and activin A signalling inhibitors3
• Copper-mediated trifluoromethylation4
• Synthesis and bioactivity of combretastatin analogs via regioselective Suzuki coupling of dihaloheteroaromatic compounds5
• Suzuki-Miyaura cross-coupling reactions6
Description (简体中文)
General description
可能含不定量的酸酐
包装
1 g in glass bottle
Application
Reactant for:
• Preparation of P1-substituted symmetry-based human immunodeficiency virus protease inhibitors with antiviral activity against drug-resistant viruses1
• Preparation of heterobiaryls via Suzuki-Miyaura cross-coupling with heteroaryl halides in continuous flow2
• Preparation of Ph and heterocyclic(pyridinyl)pyrazolyl)pyridines as TGF-1 and activin A signalling inhibitors3
• Copper-mediated trifluoromethylation4
• Synthesis and bioactivity of combretastatin analogs via regioselective Suzuki coupling of dihaloheteroaromatic compounds5
• Suzuki-Miyaura cross-coupling reactions6

REFERENCES